620 South 20th Street, NHB 104 is a clinical research site located in Birmingham, Alabama, United States.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
620 South 20th Street, NHB 104 has participated in 1 clinical trials.
Therapeutic areas: Asthma.
Sponsors: Boehringer Ingelheim.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Alabama · View every site in Birmingham
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
620 South 20th Street, NHB 104 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
620 South 20th Street, NHB 104 has 1 clinical trials on record. Their work covers Asthma.
620 South 20th Street, NHB 104 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.